Sanofi Beyfortus update
The Child Health Advantage program is offering a new Sanofi contract for offices that follow a GSK schedule. This contract provides a Beyfortus discount of just over $10 per dose.
GSK contract changes
Current membership from the GP Tier contract will be combined with the Portfolio contract membership for the market share measurements of Pediatrics, Adolescents, and Adults. This will go into effect July 1, 2024.
Furthermore, Portfolio contract members will have three new tier options to participate in. The following list contains information regarding these three tiers and their compliance requirements.
- Rotarix tier. Rota market share requirement of 80% and an additional 3% discount on Rotarix, Priorix, and Havrix.
- Arexvy tier. RSV market share requirement of 65% and an additional 1% discount on Shingrix.
- Rotarix and Arexvy tier. Rota market share requirement of 80% and an RSV market share requirement of 65%. Additional 3% discount on Rotarix, Priorix, and Havrix, as well as a 1% discount on Shingrix.
Flu pre-book
If an office is interested in pre-booking flu vaccinations for the 2024-25 year, please contact the Child Health Advantage team to access pricing through the program. The following list includes the available contracts and timeframe to receive a pre-book discount.
- AstraZeneca. Pre-book discount concludes April 30, 2024.
- GSK Flu only. Pre-book discount concludes March 31, 2024.
- Sanofi Flu. Pre-book discount concludes April 19, 2024.
- Seqirus Flu. Pre-book discount concludes April 19, 2024.
RSV
If an office is interested in purchasing RSV vaccinations through the Child Health Advantage program, the office must hold a contract with the corresponding manufacturer. The available RSV vaccinations and age requirements are listed below.
To learn more about the vaccinations, please visit their respective websites or contact the office manufacturer rep. If an office wishes to get contracted with one of the following vaccinations, contact the Child Health Advantage program.
- GSK’s Arexvy vaccination is available for adults 60 and older.
- Pfizer’s Abrysvo vaccination is available for adults 60 and older. Abrysvo is also a maternal immunization available between 32 to 36 weeks during pregnancy.
- Sanofi’s Beyfortus vaccination is available during RSV season for newborns under one year old to children up to twenty-four months who are at high risk during RSV season.
